Physician profile
Kumar Sanam
NPI 1295049575
$54,458.05
in general payments reported to CMS, 2019-2025
40 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,821 · 2020: $4,417 · 2021: $23K · 2022: $792 · 2023: $3,989 · 2024: $5,321 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Consulting Fee: $6,600 · Food and Beverage: $6,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,476.92 |
| Consulting Fee | $6,600.00 |
| Food and Beverage | $6,230.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,116.50 | 2021-2024 | Corevalve Evolut R, Na, Valiant Captivia |
| Shockwave Medical, INC | $14,131.92 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $6,733.42 | 2019-2024 | Jardiance |
| Penumbra, INC. | $2,443.49 | 2024 | Indigo System |
| Medtronic Vascular, INC. | $2,326.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $1,872.28 | 2020-2024 | Andexxa, Farxiga |
| Abiomed | $1,787.81 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $1,666.18 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $712.50 | 2020 | |
| Abbott Laboratories | $611.49 | 2023-2025 | Mitraclip, Amplatzer Talisman, Coroflow |
| Amgen INC. | $600.19 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $396.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $310.88 | 2019-2024 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $292.63 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $239.29 | 2020-2024 | Emerge Push |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kumar Sanam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.